Amedica Corporation (AMDA) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
LANCEBEAL LANCEBEAL 08/30/2016 3 months $0.97 $0.92 -5.04% -5 Active
Comments: The new sizes for silicon nitrate vertebrate implants
hprezzy hprezzy 05/15/2016 3 months $1.40 $0.67 -52.06% -52 Ended
Comments: Great product for now and the future.
MustafaIsmail MustafaIsmail 02/03/2016 3 months $2.82 $1.50 -46.81% -46 Ended
Comments:
Katerina Katerina 01/29/2016 1 month $3.09 $2.48 -19.74% -19 Ended
Comments:
rernst75 rernst75 01/28/2016 3 months $3.09 $1.70 -44.98% -44 Ended
Comments: Have brought the Chinese in$ FDA cleared.Show @neuro group soon
daxjaket daxjaket 01/28/2016 3 months $3.05 $1.70 -44.26% -44 Ended
Comments: FDA Approval Coming, Opening New Markets, New Products, Only 10M shares OS
itssofluffyimgonnadie itssofluffyimgonnadie 10/22/2015 1 week $0.24 $0.27 +13.4% -13 Ended
Comments: undervalued but still no bottom in sight
UdomLoveTey UdomLoveTey 08/05/2015 1 day $0.50 $0.50 -0.5% -1 Ended
Comments:
seifhemed2013 seifhemed2013 07/02/2015 3 months $0.60 $0.33 -45.83% -45 Ended
Comments: nice
playerprice playerprice 12/04/2014 3 months $0.71 $0.81 +14.08% 14 Ended
Comments:
villanueva villanueva 02/22/2014 1 Year $7.85 $0.80 -89.81% -89 Ended
Comments:
markrefuerzo markrefuerzo 02/22/2014 1 Year $7.85 $0.80 -89.81% -89 Ended
Comments:
Heavywchamp Heavywchamp 02/21/2014 1 Year $7.51 $0.80 -89.35% -89 Ended
Comments: Projecting strong long-term growth
Joward Joward 02/15/2014 3 months $5.68 $6.12 +7.75% 7 Ended
Comments:
RickMcD RickMcD 02/14/2014 3 months $5.65 $6.04 +6.9% 6 Ended
Comments: undervalued takeover play

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.